Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion - PubMed

Affiliations

• PMID: 21436444
• DOI: 10.1126/science.1203486

Review

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Robert D Schreiber et al. Science. 2011.

Abstract

Understanding how the immune system affects cancer development and progression has been one of the most challenging questions in immunology. Research over the past two decades has helped explain why the answer to this question has evaded us for so long. We now appreciate that the immune system plays a dual role in cancer: It can not only suppress tumor growth by destroying cancer cells or inhibiting their outgrowth but also promote tumor progression either by selecting for tumor cells that are more fit to survive in an immunocompetent host or by establishing conditions within the tumor microenvironment that facilitate tumor outgrowth. Here, we discuss a unifying conceptual framework called "cancer immunoediting," which integrates the immune system's dual host-protective and tumor-promoting roles.

Similar articles

• Cancer immunoediting: from immunosurveillance to tumor escape.

  Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Dunn GP, et al. Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991. Nat Immunol. 2002. PMID: 12407406 Review.

• Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.

  Vesely MD, Schreiber RD. Vesely MD, et al. Ann N Y Acad Sci. 2013 May;1284(1):1-5. doi: 10.1111/nyas.12105. Ann N Y Acad Sci. 2013. PMID: 23651186 Free PMC article.

• [The immune system - how does anti-tumor immunity arise ?].

  Sankawa Y. Sankawa Y. Oncol Res Treat. 2014;37 Suppl 4:2-5. doi: 10.1159/000366431. Epub 2014 Sep 30. Oncol Res Treat. 2014. PMID: 25301189 German. No abstract available.

• The immune system--is it relevant to cancer development, progression and treatment?

  Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA. Prestwich RJ, et al. Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12. doi: 10.1016/j.clon.2007.10.011. Epub 2007 Nov 26. Clin Oncol (R Coll Radiol). 2008. PMID: 18037277 Review.

• Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?

  Salih HR, Nüssler V. Salih HR, et al. Eur J Med Res. 2001 Aug 27;6(8):323-32. Eur J Med Res. 2001. PMID: 11549514 Review.

Cited by

• Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications.

  Sun W, Zhang Q, Wang R, Li Y, Sun Y, Yang L. Sun W, et al. Front Oncol. 2021 May 7;11:648687. doi: 10.3389/fonc.2021.648687. eCollection 2021. Front Oncol. 2021. PMID: 34026622 Free PMC article. Review.

• Aging, cancer, and antitumor immunity.

  Ikeda H, Togashi Y. Ikeda H, et al. Int J Clin Oncol. 2022 Feb;27(2):316-322. doi: 10.1007/s10147-021-01913-z. Epub 2021 Mar 30. Int J Clin Oncol. 2022. PMID: 33783658 Review.

• An immunoscore nomogram for predicting survival in patients with oesophageal cancer.

  Li G, Song Q, Cai A, Wei Z, Zhang R, Yi D, Chen J, Li F, Zhang Y, Liu L, Wu Y, Yi D. Li G, et al. Aging (Albany NY). 2021 Mar 10;13(6):8762-8776. doi: 10.18632/aging.202686. Epub 2021 Mar 10. Aging (Albany NY). 2021. PMID: 33714960 Free PMC article.

• Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.

  Zhang Y, Wu X, Sharma A, Weiher H, Schmid M, Kristiansen G, Schmidt-Wolf IGH. Zhang Y, et al. Front Immunol. 2022 Aug 25;13:925633. doi: 10.3389/fimmu.2022.925633. eCollection 2022. Front Immunol. 2022. PMID: 36091050 Free PMC article.

• Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

  Erkes DA, Xu G, Daskalakis C, Zurbach KA, Wilski NA, Moghbeli T, Hill AB, Snyder CM. Erkes DA, et al. Mol Ther. 2016 Aug;24(8):1444-55. doi: 10.1038/mt.2016.121. Epub 2016 Jun 10. Mol Ther. 2016. PMID: 27434584 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal